| Deborah Olszewski, | |
|
774 Waymarket Dr, Ann Arbor, MI 48103-6445 | |
| (248) 910-1306 | |
| Not Available |
| Full Name | Deborah Olszewski |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 774 Waymarket Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710330451 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 4703049827 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Olszewski, 774 Waymarket Dr, Ann Arbor, MI 48103-6445 Ph: (248) 910-1306 | Deborah Olszewski, 774 Waymarket Dr, Ann Arbor, MI 48103-6445 Ph: (248) 910-1306 |
News Archive
Boston Scientific Corporation announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus Aortic Valve System in patients with severe aortic valve disease.
A groundbreaking new treatment to combat the hospital killer bug MRSA, which is estimated to cause up to 5,000 deaths a year in Britain, is being developed by a University of Sussex scientist.
According to the World Health Organization, plastic products and their chemical derivatives present in the environment present public health concerns on a global scale and more exploration on the potential impact to human health is needed.
Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
› Verified 8 days ago
Michael Atiefu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2667 Adrienne Dr, Ann Arbor, MI 48103 Phone: 734-383-2799 | |
Lisa Heard, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Road, Ann Arbor, MI 48105 Phone: 419-259-2000 | |
Linmyers Jean Myers, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2850 S Industrial Hwy Ste 75, Ann Arbor, MI 48104 Phone: 734-677-1515 | |
Stephanie Biccum, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 517-764-3609 | |
Jacqueline Maxey, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2850 S Indurstrial Hwy, Suite 75, Ann Arbor, MI 48104 Phone: 734-477-7204 | |
Crystal Crawford, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2557 Hawks Rd, Ann Arbor, MI 48108 Phone: 734-945-3054 | |
Katrina Louise Person, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 734-222-4212 Fax: 734-845-5301 |